Back
ESC Professional Premium Access

Effect of 1st line treatment on aortic inflammation as assessed by 18 FDG PET/CT in patients with Hodgkin and non-Hodgkin lymphoma

Session: Cardio-oncology 4
Topic: Cardio-Oncology
Speaker: Doctor D. Terentes-Printzios (Athens, GR)
Event: ESC Congress 2022

Congress Presentation

Add to my library

Like

About the speaker

Doctor Dimitrios Terentes-Printzios

National & Kapodistrian University of Athens, Athens (Greece)
1 presentation
0 follower

6 more presentations in this session

Basal characteristics of the prospective spanish immunotherapy registry of cardiovascular toxicity: SIR-CVT

Speaker: Doctor E. Zatarain-Nicolas (Madrid, ES)

Access
Abstract
Slides
Like
Thumbnail

The prognostic significance of troponin level in patients with malignancy (NIHR Health Informatics Collaborative TROP-MALIGNANCY study)

Speaker: Doctor A. Kaura (London, GB)

Access
Abstract
Slides
Like
Thumbnail

COVID-19 and acute heart failure among patients with cancer

Speaker: Doctor M. Bergami (Bologna, IT)

Access
Abstract
Slides
Like
Thumbnail

Use of emgliflozine in cardiotoxicity treatment. EMPACARD-treatment registry. Six-months follow-up

Speaker: Doctor A. Daniele (Buenos Aires, AR)

Access
Abstract
Slides
Like
Thumbnail

Prognostic impact of coronary artery calcifications in patients with newly diagnosed prostate cancer

Speaker: Doctor N. Stoedkilde-Joergensen (Aarhus, DK)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Cardio-oncology 4

Speakers: Doctor D. Terentes-Printzios, Doctor E. Zatarain-Nicolas, Doctor A. Kaura, Doctor M. Bergami, Doctor A. Daniele...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources